256 related articles for article (PubMed ID: 38475811)
21. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
Flomenberg N; DiPersio J; Calandra G
Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
[TBL] [Abstract][Full Text] [Related]
22. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma.
Gilchrist A; Echeverria SL
Front Endocrinol (Lausanne); 2022; 13():846310. PubMed ID: 35399952
[TBL] [Abstract][Full Text] [Related]
23. Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Dhaiban S; Al-Ani M; Elemam NM; Maghazachi AA
J Inflamm Res; 2020; 13():619-633. PubMed ID: 33061527
[TBL] [Abstract][Full Text] [Related]
24. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.
Zabel BA; Lewén S; Berahovich RD; Jaén JC; Schall TJ
Mol Cancer; 2011 Jun; 10():73. PubMed ID: 21672222
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas.
González-Arriagada WA; García IE; Martínez-Flores R; Morales-Pison S; Coletta RD
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613922
[TBL] [Abstract][Full Text] [Related]
26. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.
Cambier S; Gouwy M; Proost P
Cell Mol Immunol; 2023 Mar; 20(3):217-251. PubMed ID: 36725964
[TBL] [Abstract][Full Text] [Related]
27. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.
Weitzenfeld P; Ben-Baruch A
Cancer Lett; 2014 Sep; 352(1):36-53. PubMed ID: 24141062
[TBL] [Abstract][Full Text] [Related]
28. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
[TBL] [Abstract][Full Text] [Related]
29. The use of chemokine receptor agonists in stem cell mobilization.
Ratajczak MZ; Kim C
Expert Opin Biol Ther; 2012 Mar; 12(3):287-97. PubMed ID: 22263752
[TBL] [Abstract][Full Text] [Related]
30. [Research Progress on the Application Strategies of Plerixafor in the Peripheral Blood Stem Cell Mobilization for Autologous Transplantation--Review].
Fang Y; Ye PP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):322-326. PubMed ID: 38387943
[TBL] [Abstract][Full Text] [Related]
31. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets.
Czaja AJ
Aliment Pharmacol Ther; 2014 Aug; 40(3):261-79. PubMed ID: 24890045
[TBL] [Abstract][Full Text] [Related]
32. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors.
Honczarenko M; Le Y; Swierkowski M; Ghiran I; Glodek AM; Silberstein LE
Stem Cells; 2006 Apr; 24(4):1030-41. PubMed ID: 16253981
[TBL] [Abstract][Full Text] [Related]
33. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
[TBL] [Abstract][Full Text] [Related]
34. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
35. GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol.
Sukhtankar DD; Fung JJ; Kim MN; Cayton T; Chiou V; Caculitan NG; Zalicki P; Kim S; Jo Y; Kim S; Lee JM; Choi J; Mun S; Chin A; Jang Y; Lee JY; Kim G; Kim EH; Huh WK; Jeong JY; Seen DS; Cardarelli PM
PLoS One; 2023; 18(10):e0287863. PubMed ID: 37878624
[TBL] [Abstract][Full Text] [Related]
36. [Chemokine and chemokine receptor related to cancer metastasis].
Yanagie H; Hisa T; Ono M; Eriguchi M
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2052-7. PubMed ID: 21084802
[TBL] [Abstract][Full Text] [Related]
37. Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
van der Voort R; Volman TJ; Verweij V; Linssen PC; Maas F; Hebeda KM; Dolstra H
Biol Blood Marrow Transplant; 2013 Mar; 19(3):378-86. PubMed ID: 23266741
[TBL] [Abstract][Full Text] [Related]
38. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
Gazitt Y; Akay C
Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
[TBL] [Abstract][Full Text] [Related]
39. Chemokines in hematopoiesis.
Broxmeyer HE
Curr Opin Hematol; 2008 Jan; 15(1):49-58. PubMed ID: 18043246
[TBL] [Abstract][Full Text] [Related]
40. Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells.
Zhang PF; Wang C; Zhang L; Li Q
Immunotherapy; 2022 Apr; 14(6):459-473. PubMed ID: 35232284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
